Search

Editors

Richard L. Cassin Publisher and Editor

Andy Spalding Senior Editor

Jessica Tillipman Senior Editor

Elizabeth K. Spahn Editor Emeritus

Cody Worthington Contributing Editor

Julie DiMauro Contributing Editor

Thomas Fox Contributing Editor

Marc Alain Bohn Contributing Editor

Bill Waite Contributing Editor

Shruti J. Shah Contributing Editor

Russell A. Stamets Contributing Editor

Richard Bistrong Contributing Editor 

Eric Carlson Contributing Editor

Bill Steinman Contributing Editor

Aarti Maharaj Contributing Editor


FCPA Blog Daily News

Entries in GlaxoSmithKline (36)

Thursday
Oct162014

Novartis employee pleads guilty in Poland bribe case

An executive at Swiss pharma Novartis pleaded guilty in a bribery prosecution in Poland, the company has confirmed.

Click to read more ...

Monday
Oct132014

With GSK, China flipped the compliance switch

GlaxoSmithKline PLC (GSK) may well be a watershed in the global fight against bribery and corruption. Behavior and conduct, which was illegal under Chinese law but previously tolerated and even accepted by Chinese government officials, quickly became a quagmire that the company was caught in when charges of corruption were leveled against them last year.

Click to read more ...

Wednesday
Oct082014

GSK investigating UAE payments following whistleblower complaint

GlaxoSmithKline said Tuesday it is investigating allegations of corrupt payments in the United Arab Emirates.

Click to read more ...

Tuesday
Oct072014

Sanofi investigating payments in Africa, Middle East

French pharma Sanofi is investigating possible illegal payments in the Middle East and Africa from 2007 to 2012 following allegations from an anonymous whistleblower.

Click to read more ...

Friday
Sep192014

China fines GSK $490 million for bribery

A court in China fined UK pharma giant GlaxoSmithKline $490 million Friday following a conviction for bribery.

Click to read more ...

Tuesday
Sep022014

A ‘cross section’ of the SFO's corporate investigations list

At the Cambridge Symposium on Economic Crime at Jesus College Tuesday, David Green QC, the head of the UK Serious Fraud Office, described what he called a cross section of the SFO's current caseload.

Click to read more ...

Tuesday
Sep022014

A briefing for compliance officers about China enforcement

Chinese regulators are stepping up anti-corruption enforcement, putting Western and local executives and the companies they work for at greater risk. So it's important to know which laws in China are most relevant and what preventive action should be taken in response to the increased enforcement.

Click to read more ...

Monday
Aug112014

Shanghai court convicts and jails Peter Humphrey and wife

The photo released by the Shanghai court shows Peter Humphrey (left) and his wife Yu Yingzeng (in red)The British investigator who once worked for GlaxoSmithKline was sentenced to two-and-a-half years in jail for trafficking personal data in China.

Click to read more ...

Tuesday
Jul292014

Matching a ‘zero tolerance’ policy with corporate action -- Part 2

In Part 1 of this series, the author probed the assertion by many companies they have "zero tolerance for unethical or illegal behavior."

In Part 2 he asks why, if most large businesses have fraud, risk and corruption-related policies in place, are there still so many cases of fraud and corruption?

Click to read more ...

Monday
Jul282014

GSK has ‘zero tolerance’ for graft: Matching company policy with corporate action (Part 1)

A recent post on FCPA Blog about various ongoing investigations into alleged corrupt practices at GlaxoSmithKline in at least five countries included a quote attributed to GSK that the company has "zero tolerance for unethical or illegal behavior."

Click to read more ...

Tuesday
Jul222014

Life is tough: In-housers bashed from all sides

In-house lawyers, we said yesterday, are now caught between their duty as advocates on the one hand, and the modern concept of ethics and compliance on the other hand. Talk about a headache.

Click to read more ...

Monday
Jul212014

Reports: GSK fired China staff in 2001 for bribes

Press reports that GlaxoSmithKline fired employees of its China unit in 2001 for paying bribes to government officials could complicate the company's defense of current allegations about illegal sales practices in several countries.

Click to read more ...